Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians

被引:12
|
作者
Yang, Zixuan [1 ]
Wen, Wei [1 ]
Jiang, Jiyang [1 ]
Crawford, John D. [1 ]
Reppermund, Simone [1 ]
Levitan, Charlene [1 ,2 ]
Slavin, Melissa J. [3 ]
Kochan, Nicole A. [1 ,4 ]
Richmond, Robyn L. [5 ]
Brodaty, Henry [1 ,3 ]
Trollor, Julian N. [1 ,6 ]
Sachdev, Perminder S. [1 ,4 ]
机构
[1] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Sch Psychiat, DCRC ABC, Sydney, NSW 2052, Australia
[4] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW 2031, Australia
[5] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia
[6] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
Advanced age; Alzheimer's disease; aMCI; brain atrophy; naMCI; structural MRI; VENTROLATERAL PREFRONTAL CORTEX; WHITE-MATTER HYPERINTENSITIES; CORPUS-CALLOSUM ATROPHY; SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; TEMPORAL-LOBE; DEFINED SUBTYPES; CEREBRAL-CORTEX; SYDNEY MEMORY; TISSUE LOSS;
D O I
10.2174/1567205013666151218150534
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Underpinnings of mild cognitive impairment (MCI) change with increasing age. We hypothesize that MRI signatures of mild cognitive impairment (MCI) would be different at a higher age compared to younger elders. Methods - 244 participants (71-103 years) from the Sydney Memory and Ageing Study and the Sydney Centenarian Study were categorized as amnestic MCI (aMCI), non-amnestic MCI (naMCI) or cognitively normal (CN). Brain "atrophy" and white matter hyper-intensities (WMHs) associated with MCI subtypes and age effects were examined by general linear models, controlling for confounding factors. Reduced logistic regressions were performed to determine structures that best discriminated aMCI from CN in individuals <85 and those >= 85 years. Results - aMCI was associated with smaller volumes of overall cortex, medial temporal structures, anterior corpus callosum, and select frontal and parietal regions compared to CN; such associations did not significantly change with age. Structures that best discriminated aMCI from CN differed however in the <85 and >= 85 age groups: cortex, putamen, parahippocampal, precuneus and superior frontal cortices in <85 years, and the hippocampus, pars triangularis and temporal pole in >= 85 years. Differences between naMCI and CN were small and non-significant in the sample. WMHs were not significantly associated with MCI subtypes. Conclusions - Structural MRI distinguishes aMCI, but not naMCI, from CN in elderly individuals. The structures that best distinguish aMCI from CN differ in those <85 from those >= 85, suggesting different neuropathological underpinnings of cognitive impairment in the very old.
引用
收藏
页码:256 / 267
页数:12
相关论文
共 50 条
  • [31] Entorhinal cortex in mild cognitive impairment and Alzheimer's disease: A structural MRI study
    Kabani, N
    Dorr, A
    Sled, JG
    Pruessner, JC
    Chertkow, H
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (02) : 246 - 247
  • [32] Alzheimer disease biomarkers and insights into mild cognitive impairment
    Knopman, David S.
    [J]. NEUROLOGY, 2013, 80 (11) : 978 - 980
  • [33] Use of VEPs as electrodiagnostic biomarkers of mild cognitive impairment
    Yamasaki, Takao
    [J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (01): : 3 - 9
  • [34] Diffusion and structural MRI as potential biomarkers in people with Parkinson's disease and cognitive impairment
    Huang, Chun-Chao
    Chen, Pei-Hao
    Tsai, Chih-Chien
    Chiang, Hsin-Fan
    Hsieh, Cheng-Chih
    Chen, Ting-Lin
    Liao, Wei-Hsin
    Chen, Yao-Liang
    Wang, Jiun-Jie
    [J]. EUROPEAN RADIOLOGY, 2024, 34 (01) : 126 - 135
  • [35] Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia
    Sonnen, Joshua A.
    Montine, Kathleen S.
    Quinn, Joseph F.
    Breitner, John C. S.
    Montine, Thomas J.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 301 - 309
  • [36] Plasma microRNA biomarkers for detection of mild cognitive impairment
    Sheinerman, Kira S.
    Tsivinsky, Vladimir G.
    Crawford, Fiona
    Mullan, Michael J.
    Abdullah, Laila
    Umansky, Samuil R.
    [J]. AGING-US, 2012, 4 (09): : 590 - U88
  • [37] Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
    Vo Van Giau
    Bagyinszky, Eva
    An, Seong Soo A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [38] Cerebrospinal fluid biomarkers in patients with mild cognitive impairment
    Nedkova Hristova, V.
    Escribano Paredes, J. B.
    Martinez Poles, J.
    Garcia Madrona, S.
    Garcia Ribas, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 241 - 241
  • [39] Diffusion and structural MRI as potential biomarkers in people with Parkinson’s disease and cognitive impairment
    Chun-Chao Huang
    Pei-Hao Chen
    Chih-Chien Tsai
    Hsin-Fan Chiang
    Cheng-Chih Hsieh
    Ting-Lin Chen
    Wei-Hsin Liao
    Yao-Liang Chen
    Jiun-Jie Wang
    [J]. European Radiology, 2024, 34 : 126 - 135
  • [40] Cerebrospinal Fluid Biomarkers and CerebralMorphometry in Mild Cognitive Impairment
    Kaiser, Elmar
    Thomann, Anne K.
    Thomann, Philipp A.
    [J]. GEROPSYCH-THE JOURNAL OF GERONTOPSYCHOLOGY AND GERIATRIC PSYCHIATRY, 2011, 24 (02) : 65 - 70